COMP <GO>
MD vs ARDT // EV/EBITDA & P/E VALUATION
Pediatrix Medical Group Inc. (NYSE) VS. Ardent Health Inc. (NYSE) • 15-METRIC TALLY: MD 3
— ARDT 2
■ METRIC PARITY
LAST: $29.18 (+0.93%) • MKT CAP: $2.37B
valuation
9.6x
LAST: $12.30 (+3.10%) • MKT CAP: $1.73B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MD VS. ARDT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MD | ARDT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 33.60% | 10.50% | +23.10 | MD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 11.43% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 2.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 6.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ARDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.7 | 57.6 | +14.02 | MD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.3x | 11.9x | +1.40 | ARDT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.37B | $1.73B | $636.1M | MD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MD REV | ARDT REV | MD GROSS % | ARDT GROSS % | MD FCF | ARDT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $6.32B | — | — | $271.1M | $470.5M |
| FY 2024 | $0 | $5.97B | — | — | $206.6M | $315.0M |
| FY 2023 | $0 | $5.41B | — | — | $137.3M | $221.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MD // BETA —
ARDT // BETA —